Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Posner

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
British Journal of Clinical Pharmacology|June 10, 2025
Intravesical antimicrobial administration for urinary tract infections via a dedicated catheterJohn Posner
British Journal of Clinical Pharmacology|June 9, 2012
Optimizing the dose of dabigatran etexilateJohn Posner
British Journal of Clinical Pharmacology|April 27, 2013
Response from John Posner, author of commentaryJohn Posner
British Journal of Clinical Pharmacology|October 13, 2011
Generic substitutionJohn Posner, John P Griffin
Frontiers in Medicine|April 3, 2023
Serum amyloid A-A potential therapeutic target for hyper-inflammatory syndrome associated with COVID-19Eman M Almusalami, Anthony Lockett, Albert Ferro, et al.
British Journal of Cancer|March 24, 2023
Revitalising cancer trials post-pandemic: time for reformCienne Morton, Richard Sullivan, Debashis Sarker, et al.
Pain|September 1, 1985
Effects of an opiate on cold-induced pain and the CNS in healthy volunteersJohn Posner, Andras Telekes, Dominic Crowley, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 22, 2006
Renal glucose excretion as a function of blood glucose concentration in subjects with type 2 diabetes--results of a hyperglycaemic glucose clamp studyKlaus Rave, Leszek Nosek, John Posner, et al.
Molecular Genetics and Metabolism|April 10, 2018
Pegvaliase for the treatment of phenylketonuria: A pivotal, double-blind randomized discontinuation Phase 3 clinical trialCary O Harding, R Stephen Amato, Mary Stuy, et al.
British Journal of Clinical Pharmacology|July 15, 2023
Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamic results of KCL-286, a novel retinoic acid receptor-β agonist for treatment of spinal cord injury, in male healthy participantsMaria B Goncalves, Tim Mant, Jörg Täubel, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
British Journal of Clinical Pharmacology|June 10, 2025
Intravesical antimicrobial administration for urinary tract infections via a dedicated catheterJohn Posner
British Journal of Clinical Pharmacology|June 9, 2012
Optimizing the dose of dabigatran etexilateJohn Posner
British Journal of Clinical Pharmacology|April 27, 2013
Response from John Posner, author of commentaryJohn Posner
British Journal of Clinical Pharmacology|October 13, 2011
Generic substitutionJohn Posner, John P Griffin
Frontiers in Medicine|April 3, 2023
Serum amyloid A-A potential therapeutic target for hyper-inflammatory syndrome associated with COVID-19Eman M Almusalami, Anthony Lockett, Albert Ferro, et al.
British Journal of Cancer|March 24, 2023
Revitalising cancer trials post-pandemic: time for reformCienne Morton, Richard Sullivan, Debashis Sarker, et al.
Pain|September 1, 1985
Effects of an opiate on cold-induced pain and the CNS in healthy volunteersJohn Posner, Andras Telekes, Dominic Crowley, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 22, 2006
Renal glucose excretion as a function of blood glucose concentration in subjects with type 2 diabetes--results of a hyperglycaemic glucose clamp studyKlaus Rave, Leszek Nosek, John Posner, et al.
Molecular Genetics and Metabolism|April 10, 2018
Pegvaliase for the treatment of phenylketonuria: A pivotal, double-blind randomized discontinuation Phase 3 clinical trialCary O Harding, R Stephen Amato, Mary Stuy, et al.
British Journal of Clinical Pharmacology|July 15, 2023
Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamic results of KCL-286, a novel retinoic acid receptor-β agonist for treatment of spinal cord injury, in male healthy participantsMaria B Goncalves, Tim Mant, Jörg Täubel, et al.
Pageof 2